Universe Pharmaceuticals INC
UPC
$4.91
-$0.21-4.10%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.73M | -13.85M | -18.97M | -12.77M | -6.58M |
| Total Depreciation and Amortization | 485.60K | 492.70K | 499.80K | 504.30K | 508.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 793.00K | 6.07M | 11.34M | 5.96M | 570.60K |
| Change in Net Operating Assets | -2.06M | -522.60K | 1.01M | 3.82M | 6.62M |
| Cash from Operations | -9.51M | -7.81M | -6.11M | -2.50M | 1.12M |
| Capital Expenditure | -245.80K | -178.50K | -111.20K | -77.70K | -44.20K |
| Sale of Property, Plant, and Equipment | 1.80K | 900.00 | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -117.20K | -58.60K | 0.00 | 0.00 | -- |
| Cash from Investing | -361.20K | -236.20K | -111.20K | -77.70K | -44.20K |
| Total Debt Issued | 14.51M | 12.06M | 9.62M | 7.65M | 5.67M |
| Total Debt Repaid | -5.55M | -6.29M | -7.03M | -7.04M | -7.06M |
| Issuance of Common Stock | 25.00M | 12.50M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.95M | 18.28M | 2.60M | 602.80K | -1.39M |
| Foreign Exchange rate Adjustments | 126.00K | -170.20K | -466.40K | -287.30K | -108.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.21M | 10.06M | -4.09M | -2.26M | -426.20K |